Vanguard Group
SQZ

Vanguard Group’s SQZ Biotechnologies Company SQZ Stock Holding History

Vanguard Group’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-941,086
Closed -$254K – 4635
2023
Q2 		$254K Sell
941,086
-666
-0.1% -$378 ﹤0.01% 4270
2023
Q1 		$527K Hold
941,752
– – ﹤0.01% 4113
2022
Q4 		$697K Buy
941,752
+348
+0% +$760 ﹤0.01% 4017
2022
Q3 		$2.15M Hold
941,404
– – ﹤0.01% 3706
2022
Q2 		$2.99M Sell
941,404
-79,399
-8% -$286K ﹤0.01% 3628
2022
Q1 		$4.91M Sell
1,020,803
-1,442
-0.1% -$9.15K ﹤0.01% 3541
2021
Q4 		$9.13M Buy
1,022,245
+6,782
+0.7% +$83.1K ﹤0.01% 3274
2021
Q3 		$14.6M Buy
1,015,463
+124,886
+14% +$1.69M ﹤0.01% 3032
2021
Q2 		$12.9M Buy
890,577
+520,995
+141% +$6.81M ﹤0.01% 3082
2021
Q1 		$5.06M Buy
369,582
+146,679
+66% +$2.98M ﹤0.01% 3526
2020
Q4 		$6.46M Buy
+222,903
New +$5.69M ﹤0.01% 3223

Other funds holding SQZ

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Vanguard Group's SQZ Position: Q3 2023 in Review

Vanguard Group sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 941,086 shares — an estimated $254K sold.

Vanguard Group first reported a position in SQZ in Q4 2020 and held it in 11 quarters. The position peaked at $14.6M in Q3 2021. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

  • Vanguard Group reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
  • Vanguard Group sold 941,086 SQZ Biotechnologies Company shares in Q3 2023, an estimated $254K.
  • Vanguard Group first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 11 quarters.
  • Vanguard Group's SQZ Biotechnologies Company position peaked at $14.6M in Q3 2021.
  • 5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Vanguard Group's 13F filing for Q3 2023, filed 14 Nov 2023.